Table 4.
Circulating humoral factors before and after the interventions of estradiol or placebo
| Variable | Estradiol | Placebo |
|---|---|---|
| Estradiol, pmol/l | ||
| Baseline | 66 ± 8 | 65 ± 9 |
| Follow up | 297 ± 25* | 62 ± 28 |
| Glucose, mmol/l | ||
| Baseline | 5.1 ± 0.1 | 4.9 ± 0.1 |
| Follow up | 5.0 ± 0.1 | 4.8 ± 0.1 |
| Insulin, pmol/l | ||
| Baseline | 91 ± 10 | 74 ± 11 |
| Follow up | 79 ± 10* | 69 ± 11 |
| Oxidized LDL, U/l | ||
| Baseline | 53.3 ± 4.7 | 58.8 ± 4.7 |
| Follow up | 56.2 ± 4.1 | 57.2 ± 4.1 |
| TAS, mmol/l | ||
| Baseline | 1.44 ± 0.04 | 1.36 ± 0.04 |
| Follow up | 1.40 ± 0.04 | 1.41 ± 0.04 |
| Endothelin-1, pg/ml | ||
| Baseline | 6.5 ± 0.4 | 6.8 ± 0.4 |
| Follow up | 6.2 ± 0.3 | 7.4 ± 0.3 |
| Glutathione peroxidase, U/l | ||
| Baseline | 7,081 ± 364 | 6,600 ± 364 |
| Follow up | 6,691 ± 353 | 6,139 ± 353 |
All data are means ± SE.
*
P < 0.05 vs. baseline of the same group.